NovaBay Pharmaceuticals, Inc.·4

Aug 24, 4:49 PM ET

Xu Wang 4

4 · NovaBay Pharmaceuticals, Inc. · Filed Aug 24, 2020

Insider Transaction Report

Form 4
Period: 2020-08-20
Xu Wang
NEO - Sr Mgr and Controller
Transactions
  • Award

    Stock Option (right to buy)

    2020-08-20+75,00075,000 total
    Exercise: $0.99From: 2021-08-20Exp: 2030-08-20Common Stock (75,000 underlying)
Footnotes (1)
  • [F1]The stock option grant will vest over four years, with 25% vesting on the first anniversary of the grant date and 6.25% vesting very three months thereafter.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4